Recent studies identified VEGF-C as a prognostic factors for poor prognosis in gastric adenocarcinoma [20], cholangiocarcinoma [21], breast cancer [22], and lung cancer [23]. This evidence concerns the gene VEGFC and cholangiocarcinoma.